HealthQuad

HealthQuad is a venture capital firm established in 2016 and based in New Delhi, India. The firm focuses on investing in innovative companies within the healthcare sector, aiming to empower entrepreneurs who are developing unique solutions to transform the prevention and treatment of illnesses. HealthQuad emphasizes a collaborative approach, positioning itself as a strategic partner rather than merely a financial backer. By providing not only capital but also valuable advice, support, and resources, HealthQuad seeks to help entrepreneurs realize their market potential. The firm leverages its extensive expertise, strong network, and rich ecosystem to foster meaningful partnerships that drive growth and innovation in healthcare.

Ajay Mahipal

Managing Director

PINAK SHRIKHANDE

Managing Director

29 past transactions

eKincare

Series C in 2025
eKincare is an innovative health benefits platform that leverages AI to provide personalized healthcare solutions. Recognized as India’s first personal health assistant, the platform integrates technology and analytics to deliver preventive and predictive health services to organizations and their employees. eKincare offers a variety of online and offline healthcare services, including 24/7 access to medical consultations, health check-ups, medication purchasing and delivery, health coaching, mental wellness programs, and fitness services. By monitoring and gathering medical data from various healthcare providers, the platform enables users to track their health information and identify potential health risks, facilitating timely interventions to enhance overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine the healthcare experience through a comprehensive and user-friendly approach.

Beta Drugs

Post in 2024
Beta Drugs is a pharmaceutical company specializing in the development and manufacturing of oncology medications. It offers a range of drug delivery systems, including tablets, capsules, oral formulations, and injections, designed to enhance patient compliance and minimize dosing errors. By focusing on simplicity and effectiveness, Beta Drugs aims to reduce drug waste while ensuring that patients can easily adhere to their treatment regimens. The company primarily operates within the Indian market but also exports its products to various international markets, with a significant portion of its revenue generated from domestic sales.

Redcliffe Labs

Series C in 2024
Redcliffe Labs is a diagnostics service provider focused on identifying both communicable and non-communicable diseases through advanced radiography and pathology services. The company offers a comprehensive range of standard and specialized tests, utilizing cutting-edge laboratories and in-house technology. Redcliffe Labs aims to enhance accessibility to health tests for all individuals in India by leveraging its trusted radiology network and innovative testing methodologies. Additionally, the company specializes in reproductive health testing, cancer gene diagnosis, and screening for rare diseases, ensuring patients receive thorough support, including regular counseling and clinical data management. Through its extensive testing capabilities, Redcliffe Labs is committed to addressing various aspects of health, pregnancy, and fertility care.

Red.Health

Series B in 2024
Red.Health is a healthcare services provider that specializes in emergency medical services, focusing on private ambulance services to enhance patient experiences throughout the emergency value chain. The company offers a diverse range of services including ambulance transportation, telemedicine, and emergency response solutions. Its ambulances are equipped with advanced diagnostic tools and come in various configurations, such as basic, advanced, and medical utility vehicles, tailored to meet specific medical needs. This ensures that patients receive prompt medical transport within minutes, accompanied by trained personnel.

CureSkin

Series B in 2024
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The application utilizes computer vision technology to analyze user-submitted photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on this analysis, CureSkin recommends suitable products, personalized treatment plans, and connects users with dermatologists for follow-ups. By leveraging artificial intelligence, the company aims to provide accessible and tailored skin care solutions, allowing individuals to effectively manage their skin health without the need for in-person consultations with trained professionals.

HealthifyMe

Series D in 2023
HealthifyMe is a fitness application that supports users in achieving their health and weight loss objectives through digital platforms, including computers and smartphones. Launched in 2012 and based in Bangalore, India, the application allows users to track calories, nutrition, and fitness activities while monitoring their weight and overall health. It also enables users to set personalized health goals and access expert advice from nutritionists and fitness trainers. The platform features an artificial intelligence-powered fitness coach that uses automated analytics to help users manage their dietary intake and receive tailored online fitness consultations. Through its comprehensive tools and expert guidance, HealthifyMe aims to enhance individual wellness and promote healthier lifestyles.

The Healthy Billion

Venture Round in 2023
THB is a prominent clinical intelligence company based in Gurugram, Haryana, founded in 2015. The company focuses on leveraging real-world evidence to enhance the healthcare ecosystem through advanced data technology solutions. By offering clinical and business modules, THB aims to improve patient outcomes and shift the healthcare industry towards data and evidence-based decision-making. With a presence in over 50 cities across more than 12 states in India, THB is dedicated to enabling data-driven healthcare and enhancing customer experience in the sector.

Technology Healthcare Big Data Analytics

Venture Round in 2023
THB is a healthcare data-technology and analytics platform enhancing decision-making and patient outcomes.

BeatO

Series B in 2022
BeatO is a health technology company that specializes in developing a comprehensive health monitoring application aimed at assisting diabetic patients in managing their condition. Founded in 2015 by Gautam Chopra, Yash Sehgal, Kunal Kinalekar, and Abhishek Kumar, the company is based in New Delhi, Delhi. BeatO's application offers a full-stack diabetes management program that enables users to track their glucose levels, manage their diet, exercise, medication intake, and receive diagnosis support. The platform features an online glucometer that records glucose readings and connects patients with healthcare professionals for real-time guidance, particularly when readings deviate from normal levels. By providing essential tools for self-management, BeatO empowers diabetic patients to maintain better control over their health.

Wysa

Series B in 2022
Wysa is a mental health wellness platform designed to assist individuals in managing stress related to social isolation and health anxiety. The platform features an AI chatbot that utilizes evidence-based cognitive-behavioral techniques to provide users with medical guidance and digital self-help resources. It also offers messaging support from professional therapists and counselors, facilitating personalized care pathways for users. By combining AI-driven support with human expertise, Wysa aims to deliver proactive behavioral health assistance directly to users' mobile devices, ensuring accessible and tailored interventions for those in need.

GoApptiv

Series A in 2022
GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

Redcliffe Labs

Series B in 2022
Redcliffe Labs is a diagnostics service provider focused on identifying both communicable and non-communicable diseases through advanced radiography and pathology services. The company offers a comprehensive range of standard and specialized tests, utilizing cutting-edge laboratories and in-house technology. Redcliffe Labs aims to enhance accessibility to health tests for all individuals in India by leveraging its trusted radiology network and innovative testing methodologies. Additionally, the company specializes in reproductive health testing, cancer gene diagnosis, and screening for rare diseases, ensuring patients receive thorough support, including regular counseling and clinical data management. Through its extensive testing capabilities, Redcliffe Labs is committed to addressing various aspects of health, pregnancy, and fertility care.

Medikabazaar

Series D in 2022
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Qure AI

Series C in 2022
Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.

eKincare

Series B in 2022
eKincare is an innovative health benefits platform that leverages AI to provide personalized healthcare solutions. Recognized as India’s first personal health assistant, the platform integrates technology and analytics to deliver preventive and predictive health services to organizations and their employees. eKincare offers a variety of online and offline healthcare services, including 24/7 access to medical consultations, health check-ups, medication purchasing and delivery, health coaching, mental wellness programs, and fitness services. By monitoring and gathering medical data from various healthcare providers, the platform enables users to track their health information and identify potential health risks, facilitating timely interventions to enhance overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine the healthcare experience through a comprehensive and user-friendly approach.

CureSkin

Series A in 2022
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The application utilizes computer vision technology to analyze user-submitted photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on this analysis, CureSkin recommends suitable products, personalized treatment plans, and connects users with dermatologists for follow-ups. By leveraging artificial intelligence, the company aims to provide accessible and tailored skin care solutions, allowing individuals to effectively manage their skin health without the need for in-person consultations with trained professionals.

Red.Health

Series A in 2022
Red.Health is a healthcare services provider that specializes in emergency medical services, focusing on private ambulance services to enhance patient experiences throughout the emergency value chain. The company offers a diverse range of services including ambulance transportation, telemedicine, and emergency response solutions. Its ambulances are equipped with advanced diagnostic tools and come in various configurations, such as basic, advanced, and medical utility vehicles, tailored to meet specific medical needs. This ensures that patients receive prompt medical transport within minutes, accompanied by trained personnel.

Medikabazaar

Series C in 2021
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

HealthifyMe

Series C in 2021
HealthifyMe is a fitness application that supports users in achieving their health and weight loss objectives through digital platforms, including computers and smartphones. Launched in 2012 and based in Bangalore, India, the application allows users to track calories, nutrition, and fitness activities while monitoring their weight and overall health. It also enables users to set personalized health goals and access expert advice from nutritionists and fitness trainers. The platform features an artificial intelligence-powered fitness coach that uses automated analytics to help users manage their dietary intake and receive tailored online fitness consultations. Through its comprehensive tools and expert guidance, HealthifyMe aims to enhance individual wellness and promote healthier lifestyles.

Medikabazaar

Series B in 2019
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Medikabazaar

Series B in 2019
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

Hi Impact

Venture Round in 2019
Hi Impact is a leading healthcare staffing company based in India, dedicated to connecting prospective doctors with healthcare employers nationwide. The company specializes in providing placements for medical professionals in hospitals, diagnostics centers, and private medical colleges. Hi Impact's platform facilitates these connections by matching candidates with suitable positions based on their qualifications, eligibility, and profile requirements. The company is committed to the success of both its clients and candidates, reflecting this commitment through its values and ethical practices.

Asian Institute Of Nephrology And Urology

Venture Round in 2019
Asian Institute of Nephrology and Urology Private Limited is a specialized renal sciences hospital located in Hyderabad, India. Established in 2011, the institute focuses on providing comprehensive medical and surgical services related to nephrology and urology. It offers a wide array of treatments for acute, chronic, and end-stage renal diseases, along with daycare and supportive services in anesthesiology, critical care, and radiology. The institution is dedicated to delivering high-quality medical care, enabling healthcare professionals to achieve excellence in patient treatment and support.

Medikabazaar

Series A in 2018
Medikabazaar is an online B2B marketplace dedicated to the procurement of medical supplies and equipment. It serves as a centralized platform for medical institutions and individual practitioners, helping them reduce operational costs while providing access to a wide range of global brands. The company connects with over 50,000 medical establishments and 150,000 independent practitioners across India, partnering with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. Medikabazaar utilizes technology to streamline the procurement process in a complex market, featuring a voice-based search engine and an online payment portal for user convenience. Its efficient last-mile delivery system, supported by 26 strategically located fulfillment centers, ensures timely delivery of essential medical supplies, thereby enhancing the quality of patient care across diverse healthcare facilities.

The Healthy Billion

Venture Round in 2018
THB is a prominent clinical intelligence company based in Gurugram, Haryana, founded in 2015. The company focuses on leveraging real-world evidence to enhance the healthcare ecosystem through advanced data technology solutions. By offering clinical and business modules, THB aims to improve patient outcomes and shift the healthcare industry towards data and evidence-based decision-making. With a presence in over 50 cities across more than 12 states in India, THB is dedicated to enabling data-driven healthcare and enhancing customer experience in the sector.

Strand

Private Equity Round in 2018
Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, specializing in the development and marketing of diagnostic tests for cancer and inherited diseases. Founded in 2000, the company offers a wide range of services, including diagnostics for oncology, genetics, fertility, women's health, infectious diseases, and general wellness. Strand provides advanced bioinformatics solutions, such as variant curation and interpretation platforms, along with its StrandOmics software for actionable insights from genomic data. The firm operates a DNA sequencing lab and has established partnerships with over 100 hospitals in India, expanding its reach into the US market. Strand's innovative software, including GeneSpring and Avadis, is utilized by 1,400 research institutions worldwide. The company emphasizes personalized medicine by identifying hereditary cancer risks and enabling tailored surveillance and risk-reduction strategies for patients. With a team of approximately 200 employees, Strand Life Sciences continues to grow in response to increasing demand for its genomic testing and interpretation services.

Asian Institute Of Nephrology And Urology

Series A in 2017
Asian Institute of Nephrology and Urology Private Limited is a specialized renal sciences hospital located in Hyderabad, India. Established in 2011, the institute focuses on providing comprehensive medical and surgical services related to nephrology and urology. It offers a wide array of treatments for acute, chronic, and end-stage renal diseases, along with daycare and supportive services in anesthesiology, critical care, and radiology. The institution is dedicated to delivering high-quality medical care, enabling healthcare professionals to achieve excellence in patient treatment and support.

Regency Healthcare

Venture Round in 2017
Regency Healthcare which started as Regency Hospital was the first, Multi-Specialty Tertiary Care Corporate Hospital in Uttar Pradesh. The Hospital was established in 1995 with a view to fill the wide gap between the demand of high quality medical services and actually available services on ground. In a span of 20 years, the hospital has been able to establish a distinct identity for delivering super specialty medical services to Kanpur, surrounding cities & rural areas.

Neurosynaptic Communications

Series A in 2016
Neurosynaptic Communications Pvt. Ltd., based in Bangalore, India, was incorporated in 2002 and focuses on providing innovative medical diagnostic equipment and healthcare delivery solutions. The company offers a range of products, including the ReMeDi-MDAU, a multi-parameter data acquisition unit, and various telemedicine and electronic medical record software solutions. Their product lineup also includes portable ECG machines, USB interface ECG devices, electronic stethoscopes, pulse oximeters, and tools for monitoring vital signs such as temperature and heart rate. Additionally, Neurosynaptic Communications develops software for patient diagnosis, prescriptions, lab investigations, and the management of medical records. The company's mission emphasizes creating a positive impact on the global rural population by making quality healthcare more accessible and affordable through its ICT-based technologies and remote diagnosis capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.